C37H50BFIN7O6 — CID 170617774
2-[3-ethoxy-5-[[(3R)-3-[4-[6-fluoro-1-(oxan-2-yl)-3-[(E)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethenyl]indazol-5-yl]-1-methylpyrazol-5-yl]oxypiperidin-1-yl]methyl]-4-iodopyrazol-1-yl]ethanol (PubChem CID 170617774) has the molecular formula C37H50BFIN7O6 and a molecular weight of 845.56 g/mol. Its IUPAC name is 2-[3-ethoxy-5-[[(3R)-3-[4-[6-fluoro-1-(oxan-2-yl)-3-[(E)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethenyl]indazol-5-yl]-1-methylpyrazol-5-yl]oxypiperidin-1-yl]methyl]-4-iodopyrazol-1-yl]ethanol.
| Compound Name | 2-[3-ethoxy-5-[[(3R)-3-[4-[6-fluoro-1-(oxan-2-yl)-3-[(E)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethenyl]indazol-5-yl]-1-methylpyrazol-5-yl]oxypiperidin-1-yl]methyl]-4-iodopyrazol-1-yl]ethanol |
|---|---|
| PubChem CID | 170617774 |
| Molecular Formula | C37H50BFIN7O6 |
| Molecular Weight | 845.56 g/mol |
| Exact Mass | 845.29 |
| IUPAC Name | 2-[3-ethoxy-5-[[(3R)-3-[4-[6-fluoro-1-(oxan-2-yl)-3-[(E)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethenyl]indazol-5-yl]-1-methylpyrazol-5-yl]oxypiperidin-1-yl]methyl]-4-iodopyrazol-1-yl]ethanol |
| SMILES | CCOc1nn(CCO)c(CN2CCC[C@@H](Oc3c(-c4cc5c(/C=C/B6OC(C)(C)C(C)(C)O6)nn(C6CCCCO6)c5cc4F)cnn3C)C2)c1I |
| InChI | InChI=1S/C37H50BFIN7O6/c1-7-49-34-33(40)31(46(43-34)16-17-48)23-45-15-10-11-24(22-45)51-35-27(21-41-44(35)6)25-19-26-29(13-14-38-52-36(2,3)37(4,5)53-38)42-47(30(26)20-28(25)39)32-12-8-9-18-50-32/h13-14,19-21,24,32,48H,7-12,15-18,22-23H2,1-6H3/b14-13+/t24-,32?/m1/s1 |
| InChIKey | PHTRQORQMQGKRY-CSMYZDSOSA-N |
| XLogP | 6.16 |
| TPSA | 123.08 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 13 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 53 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 845.56 |
| LogP ≤ 5 | 6.16 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 13 |
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'} |
|---|